In the streptozotocin-induced Alzheimer’s disease mouse model, the NLRP3 inflammasome inhibitor MCC950 protects against pathological reactive MG by inhibiting the activation of the NLRP3 inflammasome (De Oliveira et al., 2022). Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.